38
Views
62
CrossRef citations to date
0
Altmetric
Research Article

Serum matrix metalloproteinase-9 concentration in angiographically assessed coronary artery disease

, , , , , , & show all
Pages 337-342 | Published online: 08 Jul 2009

  • Dollery CM, McEwan JR, Henney AM. Matrix metalloproteinases and cardiovascular disease. Cire Res 1995; 77:863-8.
  • Celentano DC, Frishman WH. Matrix metallo-proteinases and coronary artery disease: a novel therapeutic target. J Clin Pharmacol 1997; 37:991-1000.
  • Galis ZS, Muszynski M, Sukhova GK, Simon-Morrissey E, Unemori EN, Lark MW, Amento E, Libby P. Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion. Circ Res 1994; 75:181-9.
  • Ikeda U, Takahashi M, Shimada K. Monocyteendothelial cell interaction in atherogenesis and thrombosis. Clin Cardiol 1998; 21:11-4.
  • Schroeder AP, FaIk E. Pathophysiology and inflammatory aspects of plaque rupture. Cardiol Clin 1996; 14:211-20.
  • Nikkari ST, O'Brien KD, Ferguson M, Hatsukami T, Welgus H, Alpers CE, Clowes AW. Interstitial collagenase (MMP-1) expression in human carotid atherosclerosis. Circulation 1995; 92:1393-8.
  • Shah PK, FaIk E, Badimon JJ, Fernandez Ortiz A, Mailhac A, Villareal-Levy G, Fallon JT, Regnström J, Fuster V. Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques. Circulation 1995; 95:1565-9.
  • Lee RT, Schoen FJ, Loree HM, Lark MW, Libby P. Circumferential stress and matrix metalloproteinase 1 in human coronary atherosclerosis. Implications for plaque rupture. Atterioscler Thromb Vase Biol 1966; 16:1070-3.
  • Nikkari ST, Geary RL, Hatsukami T, Ferguson M, Forough R, Alpers CE, Clowes AW. Expression of collagen, interstitial collagenase, and tissue inhibitor of metalloproteinase-1 in restenosis after carotid endarterectomy. Am J Pathol 1996; 148:777-83.
  • Galis ZS, Sukhova GK, Lark MW, Libby P. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 1994; 94:2493-503.
  • Henney AM, Wakeley PR, Davies MJ, Foster K, Hembry R, Murphy G, Humphries S. Localization of stromelysin gene expression in atherosclerotic plaques by in situ hybridization. Proc Natl Acad Sei USA 1991:88:8154-8.
  • Brown DL, Hibbs MS, Kearney M, Loushin C, Isner JM. Identification of 92-kD gelatinase in human coronary atherosclerotic lesions: association of active enzyme synthesis with unstable angina. Circulation 1995; 91:2125-31.
  • Halpert I, Sires UI, Roby JD, Potter-Perigo S, Wight TN, Shapiro SD, Welgus HG, Wickline SA, Parks WC. Matrilysin is expressed by lipid-laden macrophages at sites of potential rupture in atherosclerotic lesions and localizes to areas of versican deposition, a proteoglycan substrate for the enzyme. Proc Natl Acad Sei USA 1996; 93:9748-53.
  • Shah PK. Role of inflammation and metalloproteinases in plaque disruption and thrombosis. Vase Med 1998; 3:199-206.
  • Davies MJ. Reactive oxygen species, metalloproteinases, and plaque stability. Circulation 1998: 97:2382-3
  • Nikkari ST, Höyhtyä M, Isola J, Nikkari T. Macrophages contain 92-kd gelatinase (MMP-9) at the site of degenerated internal elastic lamina in temporal arteritis. Am J Pathol 1996; 149:1427-33.
  • Sorbi D, French DL, Nuovo GJ, Kew RR, Arbeit LA, Gruber BL. Elevated levels of 92-kd type IV collagenase (matrix metalloproteinase 9) in giant cell arteritis. Arthritis Rheum 1996; 39:1747-53.
  • Judkins MP. Selective coronary angiography. Radiology 1967; 89: 492.
  • World Medical Association Declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects. Cardiovasc Res 1997; 35:2-3.
  • Soini Y, Hurskainen T, Höyhtyä M, Oikarinen A, Autio-Harmainen H. 72 kD and 92 kD type IV collagenase, type IV collagen, and laminin mRNAs in breast cancer a study by in situ hybridization. J Histochem Cytochem 1994; 42:945-51.
  • Koenig W, Sund M, Frohlich M, Fischer HG, Lowel H, Doring A, Hutchinson WL, Pepys MB. C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. Circulation 1999; 99:237-42.
  • Kostis JB, Turkevich D, Sharp J. Association between leukocyte count and the presence and extent of coronary atherosclerosis as determined by coronary arteriography. Am J Cardiol 1984; 53:997-9.
  • Weijenberg MP, Feskens EJ, Kromhout D. White blood cell count and the risk of coronary heart disease and all-cause mortality in elderly men. Arterioscler Thromb Vase Biol 1966; 16:499-503.
  • Kalela A, Pönniö M, Koivu TA, Höyhtyä M, Huhtala H, Sillanaukee P, Nikkari ST. Association of serum sialic acid and MMP-9 with lipids and inflammatory markers. Eur J Clin Invest 2000; 30:99-104.
  • Ge J, Liu F, Gorge G, Haude M, Baumgart D, Erbel R. Angiographically "silent" plaque in the left main coronary artery detected by intravascular ultrasound. Coron Artery Dis 1995; 6:805-10.
  • Hong MK, Mintz GS, Popma JJ, Kent KM, Pichard AD, Satler LF, Leon MB. Limitations of angiography for analyzing coronary atherosclerosis progression or regression. Ann Intern Med 1994; 121:348-54.
  • Nakagomi A, Celermajer DS, Lumley T, Freedman SB. Angiographie severity of coronary narrowing is a surrogate marker for the extent of coronary atherosclerosis. Am J Cardiol 1966; 78:516-9.
  • Hirohata S, Kusachi S, Murakami M, Murakami T, Sano I, Watanabe T, Komatsubara I, Kondo J, Tsuji T. Time dependent alterations of serum matrix metalloproteinase-1 and metalloproteinase-1 tissue inhibitor after successful reperfusion of acute myocardial infarction. Heart 1997; 78:278-84.
  • Kai H, Ikeda H, Yasukawa H, Kai M, Seki Y, Kuwahara F, Ueno T, Sugi K, Imaizumi T. Peripheral blood levels of matrix metalloproteases-2 and -9 are elevated in patients with acute coronary syndromes. J Am Coll Cardiol 1998; 32:368-72.
  • Pfafferott C, Moessmer G, Ehrly AM, Bauersachs RM. Involvement of erythrocyte aggregation and erythrocyte resistance to flow in acute coronary syndromes. Clin Hemorhed Microcirc 1999; 21:35-43.
  • Mach F, Lovis C, Gaspoz JM, Linger PF, Boullie M, Urban P, Rutishauser W. C-reactive protein as a marker for acute coronary syndromes. Eur Heart J 1997; 18:1897-902.
  • Abdelmouttaleb I, Danchin N, Ilardo C, Aimone-Gastin I, Angioi M, Lozniewski A, Loubinoux J, Le Faou A, Gueant JL. C-reactive protein and coronary artery disease: additional evidence of the implication of an inflammatory process in acute coronary syndromes. Am Heart J 1999; 137:346-51.
  • Bellosta S, Via D, Canavesi M, Pflster P, Fumagalli R, Paoletti R, Bernini F. HMG-CoA reductase inhibitors reduce MMP-9 secretion by macrophages. Arterioscler Thromb Vase Biol 1998; 18:1671-8.
  • Kalela A, Laaksonen R, Lehtimäki T, Koivu TA, Höyhtyä M, Janatuinen T, Pöllänen P, Vesalainen R, Saikku P, Knuuti J, Nikkari ST. Effect of pravastatin in mildly hypercholesterolemic young men on serum matrix metalloproteinases. Am J Cardiol 2001;88:173-5.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.